SUPPRESSA, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 5.132
AS - Asia 2.379
EU - Europa 1.826
SA - Sud America 656
AF - Africa 104
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.100
Nazione #
US - Stati Uniti d'America 5.025
SG - Singapore 1.080
BR - Brasile 569
CN - Cina 501
RU - Federazione Russa 359
HK - Hong Kong 345
IT - Italia 312
SE - Svezia 285
DE - Germania 266
VN - Vietnam 193
GB - Regno Unito 129
FI - Finlandia 104
UA - Ucraina 93
FR - Francia 76
IN - India 63
CA - Canada 56
CI - Costa d'Avorio 46
ID - Indonesia 45
NL - Olanda 45
MX - Messico 33
AR - Argentina 29
BE - Belgio 26
BD - Bangladesh 25
ZA - Sudafrica 25
AT - Austria 24
JP - Giappone 24
ES - Italia 21
IE - Irlanda 16
PL - Polonia 16
IQ - Iraq 15
CL - Cile 14
LT - Lituania 14
TR - Turchia 14
CZ - Repubblica Ceca 13
CO - Colombia 11
PK - Pakistan 11
EC - Ecuador 9
MA - Marocco 8
NP - Nepal 8
VE - Venezuela 8
SA - Arabia Saudita 7
UZ - Uzbekistan 7
BG - Bulgaria 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
PY - Paraguay 5
UY - Uruguay 5
BY - Bielorussia 4
JM - Giamaica 4
JO - Giordania 4
MY - Malesia 4
TN - Tunisia 4
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
DK - Danimarca 3
IL - Israele 3
KE - Kenya 3
KG - Kirghizistan 3
NG - Nigeria 3
PE - Perù 3
TT - Trinidad e Tobago 3
AU - Australia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
LV - Lettonia 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
SN - Senegal 2
TH - Thailandia 2
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MT - Malta 1
MU - Mauritius 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 10.098
Città #
Ashburn 627
Fairfield 553
Singapore 524
Chandler 484
Woodbridge 368
Hong Kong 345
Seattle 222
Houston 220
Nyköping 219
Jacksonville 215
Cambridge 191
Wilmington 174
Beijing 161
Ann Arbor 141
New York 111
Lawrence 87
Roxbury 84
Dallas 83
Los Angeles 77
Nanjing 58
Munich 57
Bari 55
Des Moines 53
Ho Chi Minh City 52
Boardman 48
Abidjan 46
Santa Clara 43
Dearborn 42
São Paulo 41
Helsinki 40
Brooklyn 39
Jakarta 36
Princeton 35
Inglewood 34
Hanoi 33
Dong Ket 31
London 30
Buffalo 29
Nanchang 27
Ostuni 25
Brussels 24
Nuremberg 24
Frankfurt am Main 23
Moscow 23
Paris 23
San Diego 23
Rio de Janeiro 21
Tokyo 20
Hebei 19
Shenyang 19
Toronto 19
Napoli 18
Belo Horizonte 16
Denver 16
Dublin 16
Johannesburg 15
Montreal 15
The Dalles 15
Amsterdam 14
Columbus 13
Jiaxing 13
Milan 13
Pune 13
Salvador 13
San Francisco 13
Shanghai 13
Changsha 12
Chennai 12
Kunming 12
Taranto 12
Phoenix 11
Tianjin 11
Turku 11
Chicago 10
Curitiba 10
Guangzhou 10
Rome 10
Atlanta 9
Haiphong 9
Mexico City 9
Poplar 9
Redwood City 9
Vienna 9
Warsaw 9
Washington 9
Boston 8
Campinas 8
Catania 8
Guarulhos 8
Hefei 8
Manchester 8
Mumbai 8
Ankara 7
Brasília 7
Brno 7
Council Bluffs 7
Falkenstein 7
Grafing 7
Hyderabad 7
Iztacalco 7
Totale 6.499
Nome #
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 194
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 178
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 177
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società  Italiana di Medicina Interna) Study 169
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 167
Asymptomatic microhematuria: an indication of hereditary hemorrhagic telangiectasia? 161
Real-world efficacy and safety of Inclisiran: a prospective cohort study 160
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 156
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 155
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 153
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 152
Capillaroscopy of the dorsal skin of the hands in hereditary hemorrhagic telangiectasia 151
A case of sarcoidosis with isolated hepatosplenic onset and development of inflammatory bowel disease during recovery stage 149
Biliary Cystadenoma in a Female Patient with HCV-Related Liver Cirrhosis: A Case Report 147
"A secret agent" for HHT: asyntomatyc microhematuria 146
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 142
Congenital analbuminemia in a patient affected by hypercholesterolemia: A case report 142
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 139
HHT: a rare disease with broad spectrum of clinical aspects 138
Relationship between carotid intima-media thickness and non valvular atrial fibrillation type 137
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 137
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 132
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: A questionnaire-based retrospective study 131
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in Italy 125
"A secret Weapon" for diagnosis of HHT: the echo-color-Doppler study of the liver 123
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 123
The clinical labyrinth of chronic granulomatous diseases: not only sarcoidosis 122
Hereditary hemorrhagic telangiectasia: arteriovenous malformations in children. 119
Low dose intravenous bevacizumab for the treatment of anaemia in hereditary haemorrhagic telangiectasia. 116
Hepatic angiodynamic profile in paediatric patients with hereditary haemorrhagic telangiectasia type 1 and type 2 115
A new application for capillaroscopy: the study of dorsal surfaces of the hands in HHT 109
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 109
13c-methacetin breath test: a new diagnostic tool for diagnosis of liver involvement in patients affected by hereditary hemorrhagic telangiectasia 107
DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population 106
Hereditary Hemorrhagic Telangiectasia: a 15-year shorter life span 105
Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation 105
Liver involvement in a large cohort of patients with hereditary hemorrhagic telangiectasia: Echo-color-Doppler vs multislice computed tomography study 105
Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease 102
Neuroimmune activation in chronic heart failure 102
Orofacial hereditary haemorrhagic telangiectasia: High power diode laser in early and advanced lesion treatment 100
Hypogonadotropic hypogonadism associated with hereditary hemorrhagic telangiectasia 100
Hereditary Hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers 100
AST to Platelet Ratio Index (APRI) is an easy-to-use predictor score for cardiovascular risk in metabolic subjects 96
Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia 93
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 92
Diet and myocardial infarction: a nested case-control study in a cohort of elderly subjects in a Mediterranean area of southern Italy 91
Homozygous familial hypercholesterolemia in a young woman with dual gene mutations of low-density lipoprotein receptor and proprotein convertase subtilisin/kexin type 9 91
Abdominal obesity negatively influences key metrics of reverse cholesterol transport 91
Asymptomatic microhematuria: a spy of Hereditary Hemorrhagic Teleangiectasia (HHT)? 90
Pulmonary Arteriovenous Malformations and Cerebral Abscess Recurrence in a Child With Hereditary Hemorrhagic Telangiectasia. 89
Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia 89
Screening for children from families with Rendu-Osler-Weber disease: from geneticist to clinician 87
Pain and Frailty in Hospitalized Older Adults 86
Liver involvement in hereditary hemorrhagic telangiectasia: can breath test unmask impaired hepatic first-pass effect? 81
Hereditary hemorrhagic teleangiectasia: a 15-year shorter life span 80
Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab 79
Monocyte-to-HDL Ratio (MHR) Predicts Vitamin D Deficiency in Healthy and Metabolic Women: A Cross-Sectional Study in 1048 Subjects 79
Life expectancy in patients with hereditary haemorrhagic telangiectasia 78
Adipocyte fatty acid-binding protein 4 e iperlipemia familiare combinata 76
Improvement of the diagnostic accuracy of the liver shunts in hereditary hemorrhagic teleangiectasia 76
Capillaroscopic Patterns in Patients With HHT 75
Rare diseases in the elderly: a new perspective for the specialist in geriatrics 75
null 72
The lower is better”: genetic pitfalls of a paradigmatic approach for dyslipidemia 70
What changed in the Italian internal medicine and geriatric wards during the lockdown 67
Clinical features of eng- and alk1- mutation carriers 66
Novel approach to idursulfase and laronidase desensitization in type 2 and type 1 S mucopolysaccharidosis (MPS) 65
Association of fT4 and TSH with insulin resistance in aged obese euthyroid people 64
Ultrasonographic analysis of HAVMS in a large cohort of hereditary hemorrhagic telangiectasia patients: definition of a new highly-accurate intrahepatic parameter 63
Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation 62
Correlazione genotipo-fenotipo nella popolazione italiana affetta da Rendu-Osler-Weber (o Teleangiectasia Emorragica Ereditaria) 62
HHT Oro-facial manifestations: histopathological and confocal laser scanning microscopy analysis 62
Reported muscle symptoms during statin treatment amongst Italian dyslipidaemic patients in the real-life setting: the PROSISA Study 62
Studio longitudinale dell'evoluzione in età evolutiva delle malformazioni arterovenoso nella teleangiectasia emorragica ereditaria 61
Gli ammalati di Teleangiectasia Emorragica Ereditaria vivono in media 15 anni meno rispetto ai loro partners non affetti 61
Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia 61
European Reference Network for Rare Vascular Diseases (VASCERN) position statement on cerebral screening in adults and children with hereditary haemorrhagic telangiectasia (HHT) 61
Characterization of circulating endothelial cells in Hereditary Haemorrhagic Telangiectasia 60
Hereditary haemorrhagic telangiectasia: study of hepatic vascular alterations with multi-detector row helical CT and reconstruction programs 59
COGNITIVE FUNCTIONS, MOOD STATE AND QUALITY OF LIFE IN PATIENTS WITH HHT 58
Rapida ed efficiente caratterizzazione di mutazioni in pazienti con Teleangiectasia Emorragica Ereditaria mediante DHPLC 58
Il fenotipo hypertg-waist: impatto sul rischio cardiovascolare e sulla mortalità nella popolazione anziana. 57
Simplex index of insulin resistance in Hereditary Haemorrhagic Telangiectasia (HHT) patients. Preliminary data. 57
IDENTIFICATION AND VALIDATION OF THE CHRONO MED DIET SCORE: A SURVEY IN 9200 SUBJECTS 56
Improvement of the diagnostic accuracy of liver shunts in Hereditary Hemorrhagic Telangiectasia 56
Characterization of epidemiological distribution and outcome of COVID-19 in patients with hereditary hemorrhagic telangiectasia: a nationwide retrospective multi-centre study during first wave in Italy 56
Thyroid nodule malignancy is associated with increased non-invasive hepatic fibrosis scores in metabolic subjects 55
Hyperhomocysteinemia is linked to MASLD 54
Psycho-social effects regarding the job placement of hereditary hemorrhagic teleangectasia patients 53
Uso dell’angio-RM dinamica nello studio delle alterazioni parenchimali epatiche nei pazienti affetti da HHT: esperienza preliminare 53
Diagnostic delay in rare diseases: the drama of a silent killer 52
Multi-slice-ct vs dynamic time-resolved mr-angiography for evaluation of hepatic involvement in hereditary hemorragic telangiectasia 52
Minimal portosystemic encephalopathy: A new nosological entity in patients with hereditary haemorrhagic telangiectasia 51
Longitudinal study of natural history of arteriovenous malformations in evolutionary age of Hereditary Haemorrhagic Telangiectasia 50
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study 50
Dynamic MR-angiography in the evaluation of hepatic involvement in hereditary hemorrhagic telangiectasia 50
Efficacy of low-dose Bevacizumab in Hereditary Hemorrhagic Telangiectasia 50
Comment on: Atherogenic indices can predict atherosclerosis in patients with sarcoidosis 50
Manifestazioni cliniche in un'ampia coorte di pazienti pediatrici affetti da Teleangiectasia Emorragica Ereditaria 47
Rilevanza dello screening molecolare e clinico in bambini di famiglie con malattia di Rendu-Osler-Weber (o Teleangiectasia Emorragica Ereditaria) 46
Totale 9.489
Categoria #
all - tutte 47.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021632 0 0 0 0 0 77 174 49 83 115 68 66
2021/2022646 24 86 10 19 45 44 23 32 64 37 103 159
2022/20231.199 151 139 70 113 144 146 15 140 199 6 50 26
2023/2024558 36 95 39 50 49 106 25 59 7 23 18 51
2024/20252.305 94 44 132 84 93 201 248 241 94 125 318 631
2025/20262.631 734 280 313 496 582 226 0 0 0 0 0 0
Totale 10.442